Open in interactive viewer → charts, metric popovers & call review

Perella Weinberg: The Backlog Says 2027, the Stock Says Not Yet

A blowout Q3 and a nearly 3x announced backlog collide with a 22% drawdown and a pointed denial of any sale process.
PWP · Earnings Call · 2026-10-29

The quarter that finally looks like the back half

For several calls, Perella Weinberg told investors the year would be back-half weighted. Q3 made good on that promise with a jolt: “third quarter revenues of $251 million, up 53% from a year ago and up 61% from the second quarter” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-10-29. Year-to-date revenue reached $557 million, up 5%, and Q3 was the strongest quarter since Q3 2024. M&A nearly doubled year over year and rose more than 40% year-to-date, led by consumer, industrials, energy, and financial institutions. Restructuring and liability management were down against a record 2025, but management said that pipeline is building. The beat was unusually broad based. Fee-paying client count rose 50% year over year, and the number of fee events above $5 million rose nearly 80%. That is not one mega-deal carrying the quarter. It is the fee paying client count expanding, which is exactly what a scaling advisory platform is supposed to show. There is a quality caveat. CFO Alex Gottschalk noted that the $251 million included “$55 million related to closings that occurred within the first few days of the fourth quarter, which in accordance with relevant accounting principles were recorded in the third quarter” — Alexandra Gottschalk, Chief Financial Officer and Chief Operating Officer · 2026-10-29. The underlying quarter is still strong, but some Q4 revenue was pulled into Q3 by accounting. That matters for the handoff.

Backlog is a 2027 call option, not a Q4 ATM

The leading indicators are the real story. Announced and pending backlog at quarter end was up nearly 3x from a year ago. Total booked plus announced and pending backlog was up about 30% year over year. Gross backlog under engagement letters was up 40%. The pending backlog is the number that matters most, because it is the closest thing to contracted future revenue in an advisory business. But conversion timing is the catch. Andrew Bednar was explicit: “not all of that announced and pending will hit in 2026. So some of that will move into '27. There's not a whole lot in there that has any closing risk” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-10-29. The deals are signed; the closings are lumpy. That is why management has conviction into 2027 but cannot promise a smooth Q4. This is not a brand-new theme. On the May call, Bednar said announced and pending backlog was “sitting at an 8-quarter high” — Andrew Bednar, Chief Executive Officer · 2026-05-01. By October it was nearly 3x last year's level. The theme has accelerated. The company is also leaning into the middle of the market, where Bednar said “the bigger market for us is really $1 billion to $5 billion, where you're going to have probably close to 1,000 transactions” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-10-29. That is a breadth game, not a mega-deal lottery. Compensation is the other proof point. The first-nine-month adjusted comp margin was 67%, in line with the full-year target, and Q3's 62.5% margin reflected a true-up to that accrual. The company has consistently defended that 67% target. On the prior call, Bednar said “we are still targeting 67%... No change from what we said on the prior call” — Andrew Bednar, Chief Executive Officer and Chairman · 2026-07-31. Non-compensation expense is helping: adjusted non-comp was down 14% for the nine months on lower professional fees. The adjusted non compensation expense line is doing real work while revenue ramps.

The deal speculation management had to address

The genuinely new item this quarter is not a keyword. It is a denial. After late-September press reports of merger discussions with Piper Sandler, the stock jumped double digits, then round-tripped. Bednar went out of his way to address it:

Although we regularly evaluate ways to improve our position, we have never made a decision to sell the firm nor have we ever initiated any sale process. We have been building this firm for the long term. We are only 20 years in, and we continue to see tremendous opportunities in front of us.

Andrew Bednar, Chief Executive Officer and Chairman · 2026-10-29
That statement is not in the prior Q&A. It removes the bid that the press report had put under the stock and reframes PWP as a standalone scaling story. The strategy is more client coverage, selective product capability, and bolt-on acquisitions like the Gleacher Shacklock acquisition, which closed September 1 and has produced six announced transactions since. Management added 14 partners and 13 managing directors this year. The pitch is organic plus bolt-on, not for sale.

What the tape and filed numbers say

The equity does not believe the backlog yet. PWP is down 13.3% over 90 days and 22.2% from its August 13 high; it remains 47% below its January 2025 peak. The full history is up 41% since late 2020, but the recent shape is a drawdown. The last filed quarter—Q2 2026—showed total revenue of $157M, up just 1% year over year, operating income of $6M, operating margin of 3.9%, and a 2.5x price-to-revenue multiple. Price to operating income is 64.8x. If $251 million is the new run-rate, those multiples compress quickly; if it is a timing spike, they do not. The balance sheet is a help. PWP closed the quarter with $150 million in cash, no debt, and a $0.07 quarterly dividend. Leverage is liabilities-to-assets of 59%, down from a 71.7% peak. Year-to-date capital returned to equity holders was $88 million, but buybacks were temporarily limited to prioritize capital towards strategic investments such as Gleacher. That is the trade: near-term repurchases for talent and capability. The market's top themes—AI data centers, Fed rate hikes—are not PWP's tape. This is a pure advisory-cycle story with a company-specific catalyst: a backlog that supports 2027, a sale denial that removes a crutch, and a Q4 conversion test. If the announced and pending deals close on schedule, the 67% comp target and premium multiple can coexist. If they slip, the drawdown has further to run.